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66Percutaneous closure of adjunctive arteriovenous
ﬁstulas after surgical reconstruction of iliac veins
Jennifer Fahrni, MD,a and Peter Gloviczki, MD,b Aarau, Switzerland; and Rochester, Minn
In open surgical reconstruction for chronic iliofemoral and iliocaval vein obstruction, addition of an arteriovenous ﬁstula
(AVF) can improve patency. The AVF is usually taken down in a second surgical procedure several months after the initial
reconstruction. With the advancement of endovascular techniques, percutaneous closure of the ﬁstula has become an
option. We have completed percutaneous endovascular takedown of AVFs after surgical reconstruction of iliofemoral
veins in three patients using an occlusion device. Complete occlusion was achieved in all cases, and no short-term
complications were noted. Endovascular occlusion seems particularly appealing as further surgery in a groin usually
scarred by previous open procedures can be avoided. (J Vasc Surg Cases 2016;2:66-7.)Although endovascular revascularization with venous
stenting has become ﬁrst-line therapy for most cases of
chronic iliofemoral and iliocaval vein obstruction, it is not
a feasible or durable option in some patients, and open
surgical reconstruction remains the only option for some.
Patency of grafts in the venous circulation is lower than
that of grafts used for arterial reconstructions.1 One way to
try to improve patency is the addition of an arteriovenous
ﬁstula (AVF) that increases ﬂow and decreases platelet
and ﬁbrin deposition in a prosthetic graft.2,3 At our institu-
tion, we use ﬁstulas in all prosthetic femoral venous
bypasses. For Palma grafts, we use one if the vein is small
(<5 mm) or if there was an early thrombosis that needed
thrombectomy; during the second operation, we then
add an AVF. We use prosthetic grafts for all of these
AVFs. This avoids harvesting of additional veins and makes
closure of the ﬁstula with a plug uniform.
The AVF is usually taken down in a second surgical
procedure several months after the initial reconstruction.
We try to close the AVF at 3 months and at the latest
6 months after surgery. Leaving it too long might result
in intimal hyperplasia; closing it too soon might result in
graft thrombosis.
With the advancement of endovascular techniques in
the past decade, percutaneous closure of the ﬁstula has
become an option. Using vascular plugs for various lesions
has been described previously, although not in detail for
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CASE REPORT AND TECHNIQUE
The three patients had polytetraﬂuoroethylene (PTFE) AVFs
that originated from the superﬁcial femoral artery and led to the
venous bypass graft. These grafts were two venous femorofemoral
bypasses (one PTFE, one saphenous vein) and one bifurcated
PTFE graft from both iliofemoral axes to the inferior vena cava
(Fig, a). In two patients, a 7-  4-mm tapered PTFE graft was
used to create the ﬁstula; in the other one, a 6-mm PTFE graft
with external support was used with a loop conﬁguration.
Occlusion of the AVF was done 7 to 20 months after place-
ment. Twopatients received local anesthesia; one patient underwent
general anesthesia for the procedure. Percutaneous access in all pa-
tients was achieved from the contralateral superﬁcial femoral artery.
First, a 0.035-inch soft angled guidewire was used to cannulate the
contralateral iliac artery and the PTFE femoral AVF; then the guide-
wire was exchanged with a Kumpe catheter to a stiff Amplatz wire.
A 6F or 7F Ansel-2 sheath was then inserted and advanced all the
way through the contralateral iliac arteries into the common femoral
artery and the PTFE AVF. As occlusion device, we used an Amplat-
zer Vascular Plug II (St. Jude Medical, St. Paul, Minn) ranging in
size from 6 to 10 mm; a 10% to 15% oversizing results in good ﬁx-
ation and should prevent embolization (Fig, b).
The patients received 5000 units of heparin intravenously
before deployment of the plugs to minimize thrombotic
complications.
In two patients, the arteriogram at the conclusion of the
procedure showed signiﬁcantly decreased ﬂow through the AVF.
In one, theAVFoccluded immediately after the placement of the oc-
clusion device. In the other two, the ﬁstula was occluded on duplex
ultrasound at 5 months and at 6 months after the procedure. All
three patients were maintained on long-term oral anticoagulation.
DISCUSSION
The beneﬁt of an AVF of possible better graft patency
is offset by potential side effects. These include an increase
Fig. a, Arteriovenous ﬁstula (AVF) from the common femoral artery to an iliofemoral venous polytetraﬂuoroethylene
(PTFE) graft. A Silastic sheath is placed around the graft with a Prolene suture and two clips so that it can be
recognized easily and ligated if open closure is needed. b, Angiogram of the same AVF after placement of occlusion
device.
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struction and sustaining symptoms, and high-output heart
failure triggered by a high shunt volume. Takedown of the
AVF is timed according to a perceived shift from the bene-
ﬁcial effect on early graft patency to the negative effects.
As open surgical reconstruction of iliofemoral veins is
in itself a rare procedure, data on adjunctive therapies
such as AVFs and their closure or removal are also limited.
The option of endovascular occlusion of adjunctive loop
graft AVFs seems particularly appealing, as further surgery
in a groin usually signiﬁcantly scarred by previous open
procedures can be avoided.
Complete occlusion was achieved in all three of our
cases, and no short-term complications were noted.REFERENCES
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